0 NASDAQ Companies - September 3, 2019Akari Therapeutics to Participate in Citi and H.C. Wainwright Conferences in Early SeptemberRead More
0 NASDAQ Companies - September 3, 2019G1 Therapeutics to Present at H.C. Wainwright Annual Global Investment Conference on September 9, 2019Read More
0 NASDAQ Companies - September 3, 2019Valeritas Announces Oral Presentation of Preclinical h-Patch™ CBD Study at the 2nd Annual International Cannabinoid-Derived Pharmaceuticals SummitRead More
0 NASDAQ Companies - September 3, 2019Guardion Launches VectorVision CSV-2000 Standardized Contrast Sensitivity TestRead More
0 NASDAQ Companies - September 3, 2019Broadwind to Present at the H. C. Wainwright 21st Annual Global Investment ConferenceRead More
0 NASDAQ Companies - September 3, 2019uniQure Announces Achievement of Planned Enrollment in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Patients with Hemophilia BRead More
0 NASDAQ Companies - September 3, 2019Orchard Therapeutics to Webcast Presentation at the Morgan Stanley 17th Annual Global Healthcare ConferenceRead More
0 TSX News - September 3, 2019Marathon Gold Reports Latest Drill Results from Marathon Deposit at Valentine Gold Project, NLRead More
0 TSX News - September 3, 2019RioCan Announces Closing of Acquisition of KingSett Capital’s 50% Interest in Yonge Sheppard CentreRead More
0 TSX News - September 3, 2019MediPharm Labs Enters into Agreements with Australian Licensed Producer & Forms Multiple Cannabis Supply Partnerships to Advance Australian Market LeadershipRead More
